rs121918218

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_138959.3(VANGL1):​c.715G>A​(p.Val239Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000434 in 1,613,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000042 ( 0 hom. )

Consequence

VANGL1
NM_138959.3 missense

Scores

1
5
13

Clinical Significance

Uncertain significance criteria provided, single submitter P:1U:2

Conservation

PhyloP100: 5.59

Publications

18 publications found
Variant links:
Genes affected
VANGL1 (HGNC:15512): (VANGL planar cell polarity protein 1) This gene encodes a member of the tretraspanin family. The encoded protein may be involved in mediating intestinal trefoil factor induced wound healing in the intestinal mucosa. Mutations in this gene are associated with neural tube defects. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
VANGL1 Gene-Disease associations (from GenCC):
  • neural tube defects, susceptibility to
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.23214778).
BS2
High AC in GnomAd4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VANGL1NM_138959.3 linkc.715G>A p.Val239Ile missense_variant Exon 4 of 8 ENST00000355485.7 NP_620409.1 Q8TAA9-1A0A024R0E3
VANGL1NM_001172412.2 linkc.715G>A p.Val239Ile missense_variant Exon 4 of 8 NP_001165883.1 Q8TAA9-1A0A024R0E3
VANGL1NM_001172411.2 linkc.709G>A p.Val237Ile missense_variant Exon 4 of 8 NP_001165882.1 Q8TAA9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VANGL1ENST00000355485.7 linkc.715G>A p.Val239Ile missense_variant Exon 4 of 8 1 NM_138959.3 ENSP00000347672.2 Q8TAA9-1
VANGL1ENST00000310260.7 linkc.715G>A p.Val239Ile missense_variant Exon 4 of 8 1 ENSP00000310800.3 Q8TAA9-1
VANGL1ENST00000369509.1 linkc.715G>A p.Val239Ile missense_variant Exon 3 of 7 1 ENSP00000358522.1 Q8TAA9-1
VANGL1ENST00000369510.8 linkc.709G>A p.Val237Ile missense_variant Exon 4 of 8 1 ENSP00000358523.3 Q8TAA9-2

Frequencies

GnomAD3 genomes
AF:
0.0000591
AC:
9
AN:
152172
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000518
AC:
13
AN:
250772
AF XY:
0.0000738
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000417
AC:
61
AN:
1461778
Hom.:
0
Cov.:
32
AF XY:
0.0000481
AC XY:
35
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53410
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000513
AC:
57
AN:
1111914
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000591
AC:
9
AN:
152172
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41434
American (AMR)
AF:
0.0000654
AC:
1
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000121
Hom.:
0
Bravo
AF:
0.0000869
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:2
Jun 01, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies of V239I indicate that it inhibits the interaction of VANGL1 with Dvl proteins, potentially inhibiting molecular signaling during gastrulation and neural-tube closure (Kibar et al., 2007; Renolds et al., 2010); Identified in an individual with caudal regression with lipomyeloschisis, anorectal malformation, hydromyelia, and a tethered spinal cord. The V239I variant was also present in her unaffected mother and mildly affected brother who had dermal sinus (Kibar et al., 2007); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25208524, 17409324, 31589614, 20043994) -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The VANGL1 p.V239I variant was identified in 1 of 288 proband chromosomes (frequency: 0.0034) from individuals or families with caudal regression and was not identified in 212 control chromosomes from healthy individuals (Kibar_2007_PMID:17409324). The variant was identified in dbSNP (ID: rs121918218) and ClinVar (classified as likely pathogenic in 2016 by GeneDx). The variant was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 17 of 282170 chromosomes (0 homozygous) at a frequency of 0.00006025 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 15 of 128536 chromosomes (freq: 0.000117), East Asian in 1 of 19952 chromosomes (freq: 0.00005) and African in 1 of 24968 chromosomes (freq: 0.00004), but was not observed in the Latino, Ashkenazi Jewish, European (Finnish), Other or South Asian populations. The p.Val239Ile variant was identified in a 10-year-old Italian girl who had a severe form of caudal regression and was also found in her brother who had a milder form of the disease, dermal sinus (Kibar_2007_PMID:17409324). However, the variant was also found in their unaffected mother, suggesting incomplete penetrance or variable expressivity (Kibar_2007_PMID:17409324). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Val239 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. However, in a protein-protein interaction assay the p.V239I variant was found to have a deleterious affect on the protein, abolishing interaction of the VANGL1 protein with its binding partners (Kibar_2007_PMID:17409324). In a zebrafish model, knockdown/rescue experiments and overexpression assays suggested that the p.V239I variant results in a loss of function allele that affects protein function during embryonic development (Reynolds_2010_PMID: 20043994). In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -

Caudal regression sequence Pathogenic:1
Apr 05, 2007
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Uncertain
0.036
T
BayesDel_noAF
Uncertain
0.030
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.11
T;.;T;T
Eigen
Benign
-0.18
Eigen_PC
Benign
0.011
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.83
T;T;.;.
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.23
T;T;T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
1.5
L;.;L;L
PhyloP100
5.6
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.25
N;N;N;N
REVEL
Uncertain
0.46
Sift
Benign
0.35
T;T;T;T
Sift4G
Benign
0.45
T;T;T;T
Polyphen
0.13
B;B;B;B
Vest4
0.25
MVP
0.95
MPC
0.11
ClinPred
0.31
T
GERP RS
4.8
Varity_R
0.039
gMVP
0.35
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121918218; hg19: chr1-116206792; API